Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer

European Urology

Volumn 63, Issue 4, 2013, Pages 724-732

  Rink, Michael ^a,b   Furberg, Helena ^c   Zabor, Emily C ^c   Xylinas, Evanguelos ^a,d   Babjuk, Marko ^e   Pycha, Armin ^f   Lotan, Yair ^g   Karakiewicz, Pierre I ^h   Novara, Giacomo ⁱ   Robinson, Brian D ^a,j   Montorsi, Francesco ^k   Chun, Felix K ^b   Scherr, Douglas S ^a   Shariat, Shahrokh F ^a,j  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d APHP Paris Descartes University ^*  (France)

^e UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^f CENTRAL HOSPITAL OF BOLZANO   (Italy)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ UNIVERSITY OF PADOVA   (Italy)

^j NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^k VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

more..

Author keywords

Dose response relationship; Non muscle invasive bladder cancer; Progression; Recurrence; Smoking; Survival; Urothelial carcinoma

Indexed keywords

BCG VACCINE; DOXORUBICIN; EPIRUBICIN; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CYSTECTOMY; EXPOSURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NON MUSCLE INVASIVE BLADDER CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SMOKING; SMOKING CESSATION; SMOKING HABIT;

ADMINISTRATION, INTRAVESICAL; AGED; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84874546628     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.08.025     Document Type: Article

References (32)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. M. Babjuk, W. Oosterlinck, and R. Sylvester EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 2011 997 1008
3. J. Fernandez-Gomez, R. Madero, and E. Solsona Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model J Urol 182 2009 2195 2203
4. R.J. Sylvester, A.P.M. van der Meijden, and W. Oosterlinck Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 2006 466 477 discussion 475-7
5. A. Stenzl, J. Hennenlotter, and D. Schilling Can we still afford bladder cancer? Curr Opin Urol 18 2008 488 492
6. M.P. Zeegers, F.E. Tan, E. Dorant, and P.A. van Den Brandt The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies Cancer 89 2000 630 639
7. World Health Organization. World Health Organization: Global Health Risks. 2009.
8. Centers for Disease Control and Prevention Vital signs: current cigarette smoking among adults aged ≥18 years - United States, 2005-2010 MMWR Morb Mortal Wkly Rep 60 2011 1207 1212
9. N. Fleshner, J. Garland, and A. Moadel Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder Cancer 86 1999 2337 2345
10. R.J.M. Lammers, W.P.J. Witjes, K. Hendricksen, C.T.M. Caris, M.H.C. Janzing-Pastors, and J.A. Witjes Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer Eur Urol 60 2011 713 720
11. S.R. Sturgeon, P. Hartge, and D.T. Silverman Associations between bladder cancer risk factors and tumor stage and grade at diagnosis Epidemiology 5 1994 218 225
12. I.M. Thompson, M. Peek, and F.R. Rodriguez The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder J Urol 137 1987 401 403
13. NCCN clinical practice guidelines in oncology: bladder cancer 2011. National Comprehensive Cancer Network Web site. http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp.
14. M. Rink, H. Fajkovic, and E.K. Cha Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma Eur Urol 61 2012 854 855
15. N.D. Freedman, D.T. Silverman, A.R. Hollenbeck, A. Schatzkin, and C.C. Abnet Association between smoking and risk of bladder cancer among men and women JAMA 306 2011 737 745
16. S.A. Kenfield, M.J. Stampfer, J.M. Chan, and E. Giovannucci Smoking and prostate cancer survival and recurrence JAMA 305 2011 2548 2555
17. V. Cokkinides, P. Bandi, C. McMahon, A. Jemal, T. Glynn, and E. Ward Tobacco control in the United States - recent progress and opportunities CA Cancer J Clin 59 2009 352 365
18. R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
19. R.J. Sylvester, W. Oosterlinck, and A.P. van der Meijden A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials J Urol 171 2004 2186 2190 quiz 2435
20. P. Aveyard, P. Adab, K.K. Cheng, D.M. Wallace, K. Hey, and M.F. Murphy Does smoking status influence the prognosis of bladder cancer? A systematic review BJU Int 90 2002 228 239
21. S.A. Strope, and J.E. Montie The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation J Urol 180 2008 31 37 discussion 37
22. Y. Hirao, W.J. Kim, and K. Fujimoto Environmental factors promoting bladder cancer Curr Opin Urol 19 2009 494 499
23. X. Jiang, J.E. Castelao, and J.M. Yuan Cigarette smoking and subtypes of bladder cancer Int J Cancer 130 2012 896 901
24. C.A. Reznikoff, S. Sarkar, and K.P. Julicher Genetic alterations and biological pathways in human bladder cancer pathogenesis Urol Oncol 5 2000 191 203
25. S. Begum Molecular changes in smoking-related lung cancer Expert Rev Mol Diagn 12 2012 93 106
26. M.P. Zeegers, E. Kellen, F. Buntinx, and P.A. van den Brandt The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review World J Urol 21 2004 392 401
27. E.F. Schisterman, S.R. Cole, and R.W. Platt Overadjustment bias and unnecessary adjustment in epidemiologic studies Epidemiology 20 2009 488 495
28. C.H. Chen, C.T. Shun, and K.H. Huang Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer BJU Int 100 2007 281 286 discussion 286
29. R.J. Sylvester, M.A. van der, and D.L. Lamm Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials J Urol 168 2002 1964 1970
30. J.P. Sfakianos, S.F. Shariat, R.L. Favaretto, J. Rioja, and H.W. Herr Impact of smoking on outcomes after intravesical bacillus Calmette-Guerin therapy for urothelial carcinoma not invading muscle of the bladder BJU Int 108 2011 526 530
31. A.B. Alexandroff, A.M. Jackson, M.A. O'Donnell, and K. James BCG immunotherapy of bladder cancer: 20 years on Lancet 353 1999 1689 1694
32. M. Sopori Effects of cigarette smoke on the immune system Nat Rev Immunol 2 2002 372 377